Safety and tolerability study in adults with cold agglutinin disease previously treated with SAR445088 or never treated with SAR445088

Trial Identifier: LTS16637
Sponsor: Bioverativ, a Sanofi Company
Start Date: March 2021
Primary Completion Date: March 2025
Study Completion Date: March 2025
Condition: Anemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
GERMANY Essen, GERMANY, 45147
ITALY, Milano Milano, ITALY, 20122
NETHERLANDS Amsterdam, NETHERLANDS, 1081 HV
NORWAY Bergen, NORWAY, 5021
UNITED KINGDOM, London, City of London, London, City of, UNITED KINGDOM, NW1 2PG